Ml-236b derivatives, a process for their preparation and pharmaceutical compositions containing them
CA 1185199 A · Owner: Sankyo Company, Limited · Inventors: Tanaka, Minoru; Terahara, Akira
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A compound of formula (1):, (I) (called 6-methoxy-IsoML-236B lactone) and its corresponding free hydroxy-carboxylic acid and salts and esters of said acid may be prepared by the enzymatic alkoxylation of an ML-236B compound preferably using a microorganism of the genus Syncephalastrum Absidia or Cunninghamella, e.g. Absidia coerulea or a cell-free, enzyme-containing extract from said microorganism. If desired the lactone or carboxylic acid may be converted by conventional salification or esterification techniques to the desired salt or ester. These compounds have the ability to inhibit the biosynthesis of cholesterol and are thus of value in the treatment of hypercholesteraemia, for which …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 9, 1985. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 9, 2002.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.